Skip to content

Opening book details…

About this Medicine article

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1) by Llaudó, Jordi; Anta, Lourdes; Ayani, Ignacio; Martínez, Javier; Schronen, Juan; Morozova, Margarita; Ivanov, Mikhail; Gutierro, Ibón is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Llaudó, Jordi; Anta, Lourdes; Ayani, Ignacio; Martínez, Javier; Schronen, Juan; Morozova, Margarita; Ivanov, Mikhail; Gutierro, Ibón
Publisher
Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0268-1315)
Published
2016
Language
EN
Field
Medicine (Health Sciences)